Avantor Inc (AVTR)

Currency in USD
11.44
+0.08(+0.66%)
Real-time Data·
AVTR Scorecard
Full Analysis
High shareholder yield
AVTR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.1211.51
52 wk Range
10.8327.83
Key Statistics
Prev. Close
11.36
Open
11.29
Day's Range
11.12-11.51
52 wk Range
10.83-27.83
Volume
8.25M
Average Volume (3m)
12.77M
1-Year Change
-55.63%
Book Value / Share
9.22
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AVTR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
14.53
Upside
+27.01%
Members' Sentiments
Bearish
Bullish
ProTips
13 analysts have revised their earnings downwards for the upcoming period

Avantor Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Avantor Inc Company Profile

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Avantor Inc SWOT Analysis


Bioprocessing Boom
Explore Avantor's strategic pivot towards bioprocessing, a sector poised for substantial growth and representing 65% of their Bioscience Production group
Financial Resilience
Despite market challenges, Avantor demonstrates strong cost management with adjusted EBITDA margins surpassing guidance and analyst expectations
Market Dynamics
Delve into Avantor's competitive landscape, including its strong position in bioprocessing and challenges in the semiconductor market
Future Trajectory
Analysts project 8-10% long-term market growth for key segments, with price targets ranging from $25 to $34, averaging around $29.71
Read full SWOT analysis

Avantor Inc Earnings Call Summary for Q2/2025

  • Q2 2025 EPS of $0.24 missed forecast, revenue of $1.68B beat expectations; stock dropped 11.46% pre-market
  • Launched Avantor Navigator AI app and enhanced digital buying experience; stable revenue growth despite sector challenges
  • Adjusted full-year guidance: organic revenue growth -2% to flat, adjusted EBITDA margin 16.5-17%, EPS $0.94-$0.98
  • Q3 forecast: organic revenue decline 2-4%; CEO confident in platform strength despite headwinds
  • Risks include biotech funding issues, inflationary pressures, policy challenges, and supply chain disruptions
Last Updated: 01/08/2025, 14:22
Read Full Transcript

Compare AVTR to Peers and Sector

Metrics to compare
AVTR
Peers
Sector
Relationship
P/E Ratio
11.3x−0.4x−0.5x
PEG Ratio
0.120.080.00
Price/Book
1.2x0.9x2.6x
Price / LTM Sales
1.2x1.8x3.3x
Upside (Analyst Target)
23.2%143.9%45.1%
Fair Value Upside
Unlock28.5%7.4%Unlock

Analyst Ratings

9 Buy
11 Hold
0 Sell
Ratings:
20 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 14.53
(+27.01% Upside)

Earnings

Latest Release
Aug 01, 2025
EPS / Forecast
0.24 / 0.25
Revenue / Forecast
1.68B / 1.67B
EPS Revisions
Last 90 days

AVTR Income Statement

People Also Watch

26.57
CNC
+2.55%
104.14
DECK
+0.76%
741.82
AXON
-0.09%
110.36
BAH
+0.60%
183.01
IQV
+0.31%

FAQ

What Stock Exchange Does Avantor Trade On?

Avantor is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Avantor?

The stock symbol for Avantor is "AVTR."

What Is the Avantor Market Cap?

As of today, Avantor market cap is 7.77B.

What Is Avantor's Earnings Per Share (TTM)?

The Avantor EPS (TTM) is 1.01.

When Is the Next Avantor Earnings Date?

Avantor will release its next earnings report on 23 Oct 2025.

From a Technical Analysis Perspective, Is AVTR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Avantor Stock Split?

Avantor has split 0 times.

How Many Employees Does Avantor Have?

Avantor has 13500 employees.

What is the current trading status of Avantor (AVTR)?

As of 04 Aug 2025, Avantor (AVTR) is trading at a price of 11.44, with a previous close of 11.36. The stock has fluctuated within a day range of 11.12 to 11.51, while its 52-week range spans from 10.83 to 27.83.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.